CELLSENSING, created in 2014 (Canada), from 2 sister brands and 2279 competing brands. The CELLSENSING brand is owned by Theralase Technologies, a company listed in Francfort. The International Securities Identification Number (ISIN) of Theralase Technologies is CA88337V1004. CELLSENSING belongs to the Medical Devices & Instruments business sector.
Investment simulator :
Portfolio valuation
Theralase Technologies
(CELLSENSING)
over 5 years*
EUR 0.03